The quest for effective medications and therapies isn't only about what works, it's about demonstrating value...

With growing scrutiny of the role PBMs play in the pharmaceutical supply chain, we dive into the FTC’s recent administrative complaint...

Understand how life sciences companies and service providers feel about the RFP process...

Based on our own qualitative primary research conducted with payers, we have an idea on what is keeping them up at night.

Market access has had a reputation in pharma marketing for being a creative desert. However, recently that perception has been changing...

We have compiled a list of 3 things people can get wrong when it comes to p-values. Learn more...

One of the most dynamic forums for engaging and sustaining KOL-pharma relationships is the activation of an elite KOL Working Group...

Understanding decision makers’ pain points is critical to the development of value propositions. Learn about our strategies to deliver value